High-Purity 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine CAS 486460-21-3: Pharmaceutical Intermediate Manufacturer & Supplier

Discover a crucial building block for your advanced synthesis needs. We offer high-purity 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine (CAS 486460-21-3), a vital intermediate for pharmaceutical R&D and material science. Partner with a reliable manufacturer for your critical chemical supply chain.

Get a Quote & Sample

Advantages of Sourcing Our Chemical Intermediates

Uncompromised Purity

Our 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine consistently meets rigorous purity standards (≥99.0%), crucial for demanding applications in pharmaceutical synthesis and advanced material research.

Key Sitagliptin Intermediate

We are a trusted manufacturer and supplier of intermediates for blockbuster drugs. If you are looking to buy the Sitagliptin intermediate, our product CAS 486460-21-3 is a prime candidate for your formulation needs.

Global Reach & Reliable Supply

Leverage our robust supply chain as a premier chemical manufacturer and supplier in China. We ensure timely delivery and consistent availability for your ongoing projects, offering competitive prices for bulk purchases.

Applications in Modern Chemistry

Pharmaceutical Synthesis

As a key pharmaceutical intermediate, it is indispensable for synthesizing complex drug molecules, including applications like the Sitagliptin intermediate, contributing to novel therapeutic development.

Organic Synthesis

Its unique trifluoromethyl and triazolopyrazine structure makes it a versatile building block for a wide range of organic synthesis projects, enabling innovative chemical pathways.

Material Science

Researchers in material science can utilize this compound for developing new functional materials, leveraging its chemical properties for advanced applications.

Drug Discovery & Development

For R&D scientists, this intermediate is crucial for exploring new drug candidates and optimizing existing formulations, ensuring efficacy and safety in preclinical studies.